Standardized Patient-Centered Medication Review in Home Hospice (NCT03972163) | Clinical Trial Compass
CompletedNot Applicable
Standardized Patient-Centered Medication Review in Home Hospice
United States23 participantsStarted 2020-01-15
Plain-language summary
This is a pilot cluster randomized trial that tests the effect of a novel intervention that trains hospice staff to 1. regularly review, simplify, and align patients' prescribed medications with their goals of care as their illness progresses, and 2. support family caregivers with education that empowers them to understand each medication's use, develop skills for safe administration, and 3. understand when stopping medications may be beneficial.
Who can participate
Age range65 Years – 110 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Patient - Newly admitted home hospice enrollees, aged ≥65 years old with:
* 1\. advanced life-limiting illness;
* 2\. an estimated life expectancy of \>1 month;
* 3\. recent functional status decline (defined as change in Karnofsky Performance Status \[KPS\] to \< 80% in prior 3 months);
* 4\. polypharmacy (defined as ≥ 5 regularly scheduled medications \[excluding antimicrobials\]);
* 5\. cognitive ability to provide informed consent based on a Short Portable Mental Status Questionnaire (SPMSQ) score ≥6 OR, with a legally authorized representative who is willing and able to provide proxy consent.
Family ("any relative, partner, friend or neighbor who has a significant personal relationship with, and provides a broad range of assistance) Caregiver -
* self-identification as "usually" or "always" providing care to the eligible patient;
* English-speaking;
* telephone access; and
* cognitive ability to participate.
Exclusion Criteria:
Patient:
* Imminent death;
* pain crisis;
* no family caregiver or health care proxy
Family Caregiver:
* no telephone access;
* cognitive impairment.